POTASSIUM CHLORIDE | A076368 | ADARE PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition From Hyman, Phelps & McNamara , P.C. FDA-2014-P-0328 · 4 docket documents Hyman, Phelps & McNamara, P.C. filed this citizen petition requesting that FDA designate K-Tab (potassium chloride extended release tablets, USP, 20 meq., NDA No. 18279) as a Reference Listed Drug in the Orange Book to allow generic applicants to submit ANDAs referencing this product, since the curr | 505(q) | 2014-03-28 | Granted | Hyman, Phelps & McNamara , P.C. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1349
per ea
Lowest NADAC/Unit
$0.1347
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 63304007605POTASSIUM CL ER 10 MEQ TABLET | $0.1349 | EA | Generic | — | 2026-06-17 |
| 63304007610POTASSIUM CL ER 10 MEQ TABLET | $0.1349 | EA | Generic | — | 2026-06-17 |
| 60687063201POTASSIUM CL ER 10 MEQ TABLET | $0.1349 | EA | Generic | — | 2026-06-17 |
| 63304007601POTASSIUM CL ER 10 MEQ TABLET | $0.1349 | EA | Generic | — | 2026-06-17 |
| 63304098701POTASSIUM CL ER 20 MEQ TABLET | $0.1347 | EA | Generic | — | 2026-06-17 |
| 63304098705POTASSIUM CL ER 20 MEQ TABLET | $0.1347 | EA | Generic | — | 2026-06-17 |
| 63304098710POTASSIUM CL ER 20 MEQ TABLET | $0.1347 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.